AChE/BuChE-IN-4
AChE/BuChE-IN-4 (compound 4a) is aorally activeandbrain-penetrantmultitarget-directedAChE/BuChEinhibitor againstAChEandBuChE, with theIC50of 2.08 and 7.41 μM[1].
Product Specifications
CAS Number
[1997158-25-4]
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ache-buche-in-4.html
Purity
99.66
Solubility
DMSO : ≥ 125 mg/mL
Smiles
NC1=NC=CC(NCC2CCN(CC2)CC3=CC=CC=C3)=N1
Molecular Formula
C17H23N5
Molecular Weight
297.40
References & Citations
[1]Conceição RAD, et al. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease [published online ahead of print, 2023 Oct 5]. J Cell Biochem. 2023;10.1002/jcb.30483.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6294315-01 0.2 mL
EDA2R, CT (EDA2R, TNFRSF27, XEDAR, Tumor necrosis factor receptor superfamily member 27, X-linked ectodysplasin-A2 receptor) (Biotin)
Ask
View Details MBS6294315-02 5x 0.2 mL
EDA2R, CT (EDA2R, TNFRSF27, XEDAR, Tumor necrosis factor receptor superfamily member 27, X-linked ectodysplasin-A2 receptor) (Biotin)
Ask
View Details